RxDoctor Payments Data

Caroline Day, MD

Family Medicine · Saint Louis, MONPI 1093860652

Payments from drug & device makers

$232in general payments, 2019–2025

Across 13 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$69
  • Pfizer$42
  • Sanofi Pasteur Inc.$24
  • Quidel Corporation$23
  • Johnson & Johnson$21
  • Dexcom, Inc.$19
  • plus $34 from 2 others

What the payments were for

  • Food & beverage$232100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$232 in reported general payments places this provider in the 40th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$476
Medicare patients
28
Services billed
68

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide65$57,846
JardianceEmpagliflozin46$57,619
OzempicSemaglutide40$42,509
JanuviaSitagliptin Phosphate31$27,707
EliquisApixaban19$22,048
XareltoRivaroxaban29$17,994
MounjaroTirzepatide12$12,303
TradjentaLinagliptin20$11,145
Breo ElliptaFluticasone/Vilanterol27$10,498
FarxigaDapagliflozin Propanediol13$7,360
SavellaMilnacipran Hcl13$6,378
Spiriva RespimatTiotropium Bromide12$6,311
SymbicortBudesonide/Formoterol Fumarate26$6,117
Combivent RespimatIpratropium/Albuterol Sulfate11$5,319
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$5,235

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$69$42,50940 claims
PfizerEliquis$42$22,04819 claims
Johnson & JohnsonXarelto$21$17,99429 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →